COPD Clinical Trial
Official title:
The Safety and Feasibility of Re-treating Patients With Severe Emphysema With the RePneu LVRC System: a Pilot Study.
Rationale:
The combined data from 3 studies outside the Unites States investigating the Lung Volume
Reduction Coil system (RePneu LVRC) showed statistically significant improvements in
pulmonary function, exercise capacity and quality of life at both 6-Months and 12-Months
post treatment. 24 months post treatment the improved pulmonary function and exercise
capacity are slightly decreasing. Retreating the patient with the LVR coil system in other
parts of the lung could potentially lead to new improvements in lung function, dyspnea,
exercise capacity and quality of life and may reduce the rate of decline.
Objective:
To investigate the safety and feasibility of re-treating patients with severe Chronic
Obstructive Pulmonary Disease (COPD) with the RePneu LVRC system.
Rationale:
The combined data from 3 studies outside the Unites States investigating the Lung Volume
Reduction Coil system (RePneu LVRC) showed statistically significant improvements in
pulmonary function, exercise capacity and quality of life at both 6-Months and 12-Months
post treatment. 24 months post treatment the improved pulmonary function and exercise
capacity are slightly decreasing. Retreating the patient with the LVR coil system in other
parts of the lung could potentially lead to new improvements in lung function, dyspnea,
exercise capacity and quality of life and may reduce the rate of decline.
Objective:
To investigate the safety and feasibility of re-treating patients with severe Chronic
Obstructive Pulmonary Disease (COPD) with the RePneu LVRC system.
Study design:
This study is a non randomized uncontrolled intervention.
Study population: Patients with severe emphysema who have previously been treated with the
lung volume reduction coil system and significantly improved in lung function, exercise
capacity or quality of life, 6 months after the treatment.
Intervention:
Patients will receive a lung volume reduction coil treatment by bronchoscopy.
Main study parameter:
The safety objective of this study is to identify the potential number and type of
device-related and procedure-related adverse effects.
Secondary study parameters:
Lung function
- Change in RV, 6 months following treatment
- Change in RV/TLC ratio, 6 months following treatment
- Changes in FEV1 and FVC, 2 and 6 months following treatment
Quality of life
- Change in the SGRQ score, 2 and 6 months following treatment
- Change in the CCQ score, 2 and 6 months following treatment
Functional measures
- Change in the mMRC score, 2 and 6 months following treatment
- Change in the 6MWD, 2 and 6 months following treatment
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06000696 -
Healthy at Home Pilot
|
||
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Completed |
NCT04105075 -
COPD in Obese Patients
|
||
Recruiting |
NCT05825261 -
Exploring Novel Biomarkers for Emphysema Detection
|
||
Active, not recruiting |
NCT04075331 -
Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial
|
Phase 2/Phase 3 | |
Terminated |
NCT03640260 -
Respiratory Regulation With Biofeedback in COPD
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|
||
Withdrawn |
NCT04210050 -
Sleep Ventilation for Patients With Advanced Hypercapnic COPD
|
N/A | |
Terminated |
NCT03284203 -
Feasibility of At-Home Handheld Spirometry
|
N/A | |
Recruiting |
NCT06110403 -
Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06040424 -
Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Recruiting |
NCT04868357 -
Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program
|
N/A | |
Completed |
NCT01892566 -
Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV
|
N/A | |
Completed |
NCT04119856 -
Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD
|
N/A | |
Completed |
NCT04485741 -
Strados System at Center of Excellence
|
||
Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
Recruiting |
NCT04860375 -
Multidisciplinary Management of Severe COPD
|
N/A |